|
|||||
|
|
Effects on α‐ and β‐cell function of sequentially adding empagliflozin and linagliptin to therapy in people with type 2 diabetes previously receiving metformin: An exploratory mechanistic study |
|
| Authors: | Thomas Forst MD Alexander Falk MD Grit Andersen MD Annelie Fischer PhD Matthias M. Weber MD Stephan Voswinkel MD Tim Heise MD Christoph Kapitza MD Leona Plum‐Mörschel MD |
| Affiliation: | 1. Profil, Neuss, Germany;2. 1st Medical Department, Endocrinology, Johannes Gutenberg University, Mainz, Germany;3. MLM Medical Laboratories, Moenchengladbach, Germany;4. Profil, Mainz, Germany |
| Abstract: | |
| Keywords: | α ‐cell function β ‐cell function DPP‐4 inhibition SGLT‐2 inhibition |